| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| May 19, 2022 | May 23, 2022 | Opus Genetics, Inc. | CEO | Buy | 90.0 | +25,000 | 6.25% | ✗ | $51.2K |
| Aug 10, 2016 | Aug 12, 2016 | MetaVia Inc. | CEO | Buy | 92.5 | +53,712 | 8.23% | ✗ | $533.1K |